Shares in Avinger (NSDQ:AVGR) fell today after the medical device developer missed expectations on Wall Street with its 2nd quarter earnings results. The Redwood City, Calif.-based company posted losses of $12.8 million, or 54¢ per share, on sales of $2.5 million for the 3 months ended June 30, seeing losses shrink 5.2% while sales shrunk 47.5% compared […]
Avinger
Clever catheter lets surgeons see inside arteries to trim plaque
The Pantheris catheter developed by Avinger takes the physician out of the radiation field. A clever catheter design lets cardiologists see inside arteries and precisely remove plaque from diseased tissue. The Pantheris catheter is safer than conventional radiation-guided procedures because it takes the surgeon out of the radiation field, and along with on-board optics, it […]
Avinger touts 2-year Pantheris study data
Avinger today released data from the pivotal vision study of its Pantheris system, touting high survivability and freedom from target lesion revascularization in patients treated with the system. The 89-patient Vision study aimed to evaluate the safety and effectiveness of its Pantheris directional atherectomy system which uses real-time intravascular imaging to remove plaque from diseased […]
Avinger shares dive on Q1 miss
Shares in Avinger have fallen over 15% today after the medical device maker missed expectations on Wall Street with its 1st quarter earnings results. The Redwood City, Calif.-based company posted losses of $15.3 million, or 64¢ per share, on sales of $3.5 million for the 3 months ended March 31, seeing losses shrink 5.1% while […]
Avinger to lay off a third of workforce
Avinger (NSDQ:AVGR) said yesterday that it plans to lay off a third of its workforce and examine its “strategic alternatives” as it focuses on its Pantheris peripheral artery device. The layoffs, affecting 131 workers, are slated to be complete this week, the Redwood City, Calif.-based company said, including cutting its field sales force by nearly half, from […]
Avinger tumbles on Q4 revenue miss
Shares in Avinger (NSDQ:AVGR) dropped today after the medical device maker missed expectations on Wall Street with its 4th quarter results. The Redwood City, Calif.-based company posted losses of -$13.5 million, or -58¢ per share, on sales of $4.7 million for the 3 months ended Dec. 31, for bottom-line loss of -0.3% on sales growth of 64% compared […]
Avinger touts 2-year Pantheris study data
Avinger (NSDQ:AVGR) today released 2-year interim data from the pivotal Vision trial of its Pantheris system, touting high rates of freedom from target lesion revascularization. The study aimed to analyze the effectiveness of the Pantheris during directional atherectomy procedures, the Redwood City, Calif.-based company said. The Pantheris device is designed to be used to identify vessel lumen […]
Avinger shares drop on Q4 prelims
Avinger (NSDQ:AVGR) saw shares prices drop -12% today after it released preliminary financial results for the 4th quarter, missing analysts’ expectations on Wall Street. The Redwood City, Calif.-based company said it expects a total revenue of $4.7 million, up 62% over Q4 2015 but down -11% from the 3rd quarter. Revenue from disposable devices is expected to be $3.7 million, […]
FDA expands clearance for Avinger’s Lightbox L250 vascular imaging console
Avinger (NSDQ:AVGR) said today that it won 510(k) clearance from the FDA for its Lightbox L250 imaging console. The software is designed to improve visualization inside vessels before, during and after Pantheris Lumivascular atherectomy procedures in patients with peripheral artery disease. “The ability to obtain an accurate and real-time measurement from inside a diseased vessel is […]
Endurance through criticism: The legendary career of Dr. John Simpson
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them! Dr. John Simpson. Even if you’re a medical device newbie, you’ve probably heard of him. He’s credited with inventing and commercializing the first over-the-wire balloon catheter used […]
FDA adds diagnostic indication for Avinger’s Pantheris atherectomy device
Avinger (NSDQ:AVGR) said today it won expanded indications from the FDA for its Pantheris Lumivascular atherectomy system, now cleared for diagnostic imaging as well as treatment for peripheral artery disease. The Redwood City, Calif.-based company touted the win, saying its Pantheris is the 1st and only image-guided atherectomy device to receive clearances as both a diagnostic […]